Avacta Group (LON:AVCT) Trading Up 12.7% – What’s Next?

Avacta Group Plc (LON:AVCTGet Free Report) was up 12.7% during mid-day trading on Tuesday . The company traded as high as GBX 31 ($0.42) and last traded at GBX 31 ($0.42). Approximately 3,044,731 shares were traded during mid-day trading, an increase of 80% from the average daily volume of 1,689,436 shares. The stock had previously closed at GBX 27.50 ($0.37).

Avacta Group Stock Performance

The firm has a 50 day moving average of GBX 34.82 and a 200-day moving average of GBX 42.17. The company has a market cap of £117.77 million, a P/E ratio of -3.99 and a beta of 1.12. The company has a quick ratio of 4.96, a current ratio of 1.29 and a debt-to-equity ratio of 52.53.

About Avacta Group

(Get Free Report)

Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics.
The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US.

Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).

Recommended Stories

Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.